Evolus’ Post

View organization page for Evolus, graphic

21,064 followers

Looking back at David Moatazedi's insightful interview on the Schwab Network with Oliver Renick, it's amazing to see how far Evolus has come. During the conversation, David shared how Evolus has captured a significant 13% share of the market and built our brand as the fastest-growing neurotoxin for three consecutive years in the U.S. From expanding our presence in clinics to evolving beyond a single-product company, our journey has been defined by continuous #innovation. Our recent foray into dermal fillers is a testament to our commitment to becoming a leading multi-product #performance beauty brand. As we continue to build on this momentum, we're excited to share more about our growth trajectory and the strength of our business. We look forward to providing additional details on our vision for the future at our upcoming Investor Day on September 12th in New York City. Stay tuned! See the full interview here: https://lnkd.in/eKSnc7E9 Register here: https://lnkd.in/eTqAxXFr $EOLS #Evolus #EvolveWithUs #PerformanceBeauty #MedicalAesthetics

Evolus (EOLS) CEO on Outlook of Performance Beauty Products | Schwab Network

Evolus (EOLS) CEO on Outlook of Performance Beauty Products | Schwab Network

schwabnetwork.com

To view or add a comment, sign in

Explore topics